| HOME >> BIOLOGY >> TECHNOLOGY |
"The incubator program is an important way for UCLA to make the fruits of our world-class faculty's research available to the public as rapidly as possible," said UCLA Chancellor Gene Block. "California looks to universities like UCLA for innovative technology. It is fitting then to have these startup companies embedded within the CNSI, whose mission is to fuel economic development by nurturing novel technologies and transferring them from the lab to the clinical arena and commercial market."
"We look forward to working with MediSens to move the technology to product development," said Sarrafzadeh. "The collaborative research environment at CNSI is invigorating, and we are delighted to have MediSens in lab space that benefits from UCLA's great resources.
"We hope that this technology will help to reduce the large number of injuries caused by diabetic foot ulcers and by falls each year, both in hospital rehabilitation departments and in at-home care environments," Sarrafzadeh said.
"We anticipate great success for MediSens as it continues to develop products based on the convergence of computer science and engineering technology with medical and health applications," said Leonard H. Rome, interim director of the CNSI and senior associate dean for research at the David Geffen School of Medicine at UCLA. "CNSI is committed to facilitating collaborations with private industry for the rapid commercialization of new innovations, and we are excited to welcome this startup into the incubator space as it carries out its essential R&D."
Sarrafzadeh is also a co-director of the Wireless Health Institute (WHI) at UCLA, which is dedicated to improving the timeliness and reach of health care through the development and application of wireless, network-enabled technologies integrated with current and next-generation medical enterprise co
'/>"/>
| Contact: Jennifer Marcus jmarcus@cnsi.ucla.edu 310-267-4839 University of California - Los Angeles Source:Eurekalert |